Open Access

Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized and controlled pilot study

  • David J Leehey1, 5Email author,
  • Irfan Moinuddin2,
  • Joseph P Bast1,
  • Shahzad Qureshi1,
  • Christine S Jelinek2,
  • Cheryl Cooper3,
  • Lonnie C Edwards1,
  • Bridget M Smith4 and
  • Eileen G Collins2, 6
Cardiovascular Diabetology20098:62

https://doi.org/10.1186/1475-2840-8-62

Received: 20 July 2009

Accepted: 9 December 2009

Published: 9 December 2009

Abstract

Background

Patients with obesity, diabetes, and chronic kidney disease (CKD) are generally physically inactive, have a high mortality rate, and may benefit from an exercise program.

Methods

We performed a 24-week randomized controlled feasibility study comparing aerobic exercise plus optimal medical management to medical management alone in patients with type 2 diabetes, obesity (body mass index [BMI] > 30 kg/m2), and stage 2-4 CKD (estimated glomerular filtration rate [eGFR] 15-90 mL/min/1.73 m2 with persistent proteinuria). Subjects randomized to exercise underwent thrice weekly aerobic training for 6 followed by 18 weeks of supervised home exercise. The primary outcome variable was change in proteinuria.

Results

Seven subjects randomized to exercise and 4 control subjects completed the study. Exercise training resulted in an increase in exercise duration during treadmill testing, which was accompanied by slight but insignificant decreases in resting systolic blood pressure and 24-hour proteinuria. Exercise did not alter GFR, hemoglobin, glycated hemoglobin, serum lipids, or C-reactive protein (CRP). Caloric intake and body weight and composition also did not change with exercise training.

Conclusion

Exercise training in obese diabetic patients with CKD is feasible and may have clinical benefits. A large-scale randomized controlled trial to determine the effects of exercise on renal functions, cardiovascular fitness, inflammation, and oxidative stress in diabetic patients with CKD is planned.

Background

Diabetes mellitus now affects approximately 250 million people worldwide, a figure expected to reach 400 million (approximately 7% of the adult population) by 2025 [1]. This global epidemic of diabetes is in large part due to obesity and sedentary lifestyle. Increasing numbers of patients with diabetic complications will impose an enormous burden on the healthcare system [2, 3]. Kidney disease is the most feared complication of diabetes, due to its substantial co-morbidity (need for dialysis, blindness, amputations, etc.), cost, and mortality (the annual mortality rate of diabetic patients with kidney failure on dialysis is about 25%) [4]. The major determinants of kidney disease and its progression to end-stage kidney failure in type 2 diabetes are uncontrolled blood glucose, blood pressure and albuminuria [57]. The Steno-2 study provides good evidence that further improvements in outcome can only be achieved through multifactorial intervention, consisting of lifestyle modifications in addition to pharmacologic measures [8].

Regular exercise with [9, 10] or without [9, 11, 12] dietary intervention and/or oral blood glucose-lowering medication [13, 14] has been shown to have benefits in patients with Type 2 diabetes. However, most of these studies were done in subjects with newly-diagnosed diabetes without complications and/or only insulin resistance. Current guidelines from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes recognize the value of exercise [1517]. However, there is no evidence that exercise will prevent or ameliorate complications such as chronic kidney disease (CKD) in this population.

The present study seeks to investigate the hypothesis that increasing energy expenditure by aerobic exercise will have cardiovascular benefits, including decreased blood pressure, decreased heart rate, and increased exercise tolerance, and will result in a decrease in proteinuria in obese diabetic patients with CKD. We also wished to determine if exercise would result in weight loss and improved body composition, improved glucose and lipid control, and a decrease in inflammation.

Methods

Study Design

This was a 24-week randomized controlled pilot study. After baseline screening, subjects were randomized to an exercise or control group. Subjects randomized to exercise underwent thrice weekly training for 6 weeks in the research exercise laboratory at Hines VA Hospital, followed by 18 weeks of supervised home exercise. Both groups received standard of care medical treatment for diabetes and CKD, including diabetes education. The primary outcome variable was change in proteinuria. Exercise training parameters (resting and maximal blood pressure, heart rate, and oxygen consumption), hemoglobin, glycated hemoglobin, lipid profile, C-reactive protein (CRP), dietary caloric intake, and body weight and composition were secondary outcome variables. This research was carried out in compliance with the Helsinki Declaration and was approved by the Hines VA IRB. Written informed consent was obtained from each participant.

Study Sample

Our study sample consisted of 20 subjects from the renal outpatient clinic of Hines VA Hospital with type 2 diabetes, obesity (BMI > 30 kg/m2), and stage 2-4 CKD (eGFR 15-90 mL/min/1.73 m2 with persistent proteinuria, i.e. urine protein/creatinine > 200 mg/g for ≥ 3 months) (see Table 1 for inclusion and exclusion criteria).
Table 1

Study Inclusion and Exclusion Criteria

Inclusion Criteria

Exclusion Criteria

CKD Stages 2-4

CKD stages other than 2-4

BMI ≥ 30

Hyperparathyroidism/osteoporosis

Diabetes mellitus

Symptomatic neuropathy/retinopathy

Proteinuria (urine protein/creatinine > 200 mg/g for ≥ 3 months)

Positive stress test due to coronary arterial disease

Treatment with ACE inhibitor or ARB, aspirin, and statin (if LDL > 100)

Symptomatic cardiovascular disease

Congestive heart failure (New York Heart Association Class III or IV)

Chronic obstructive pulmonary disease (FEV1 < 50% predicted and/or requires supplemental oxygen support during exercise)

Complaints of angina during the stress test

Cerebrovascular disease/cognitive impairment

Renal transplant

Inability to walk on the treadmill

Any unforeseen illness or disability that would preclude exercise testing or training

Participation in a formal exercise program within the previous 12 weeks

BMI = body mass index (kg/m2), FEV1 = forced expiratory volume in one second; ACE = angiotensin converting enzyme; ARB = angiotensin receptor blocker; LDL = low density lipoprotein

Study Procedures

All subjects underwent a full history and physical examination and an electrocardiogram (ECG). They then underwent a symptom-limited, treadmill, exercise stress test. If the stress test was negative, the patient was continued in the study and asked to complete questionnaires, nutritional assessment, and laboratory tests. After all baseline data were obtained, if patients were still eligible, they were randomized using a 2 × 2 block randomization scheme to the exercise or control group. The above testing was repeated after 6 weeks (at the end of the training period) and 24 weeks (end of study).

Aerobic Training Protocol

Individuals assigned to the exercise group received instruction in walking and proper walking shoe selection. An introductory session was completed to educate the patient on developing a walking program, familiarize him/her with the lab and practice walking on treadmill. Each exercise training session included 3 to 5 minutes of warm-up, range-of-motion exercises, interval training, cool-down, and post-exercise range-of-motion exercises. Each subject's training program was individualized and based on the results of the baseline exercise tests. Exercise intensities listed in Table 2 served as a guide for exercise prescription. Total exercise time began at 30 minutes and gradually increased by 5 minutes every two weeks. Patients were not allowed to exercise at a heart rate beyond that achieved on the maximal exercise test. Training was completed on the treadmill, outside (weather permitting) or in the research building corridors. After six weeks of supervised training, subjects were expected to continue their walking program unsupervised in their community and to increase their step count/structured walk by 10% each week. Study staff called them weekly to ask about step counts and their walking program.
Table 2

Exercise Training Schedule

Weeks

Light

(25-44% VO2 peak)

Moderate

(45-59% VO2 peak)

Hard

(60-84% VO2 peak)

Very Hard

(>85% VO2 peak)

1-3

20% (6 min)

60% (18 min)

20% (6 min)

0%

4-6

15% (6 min)

55% (22 min)

30% (12 min)

0%

Percent time spent at a given exercise training intensity (% peak VO2) for exercise group (approximate minutes at each intensity are in parenthesis). Values expressed in the table are a percentage of the total workout time (e.g., 10 min of a 30 minute workout = 33%). Total exercise time begins at 30 minutes and increases by 5 minutes every two weeks until 40 minutes is achieved while supervised.

Exercise-induced Hypoglycemia

To prevent exercise-induced hypoglycemia, patients were exercised one to two hours after a meal (generally after breakfast). A fingerstick blood glucose was performed prior to exercising; if the glucose was <110 mg/dL, 30 g of carbohydrate was administered prior to exercising.

Control group protocol

Control patients underwent the same testing battery but did not participate in any exercise training.

Specific Methods

Symptom-limited treadmill test protocol

Subjects exercised on a treadmill (Marquette Series 2000 treadmill) attached to an ECG monitor. Exercise began at 0% grade and a speed of 1.8 mph. Increases in percent grade occurred every 30 seconds, and, after the first six minutes, speed increased every three minutes. The following measurements were made during all exercise tests. Oxygen uptake was determined using the MedGraphics CPX/MAX/D™ system for breath by breath analysis (St. Paul, MN). Prior to each test, the analyzers were calibrated with reference gases and room air. Heart rate was derived from a standard ECG. A Marquette CASE (Cardiac Assessment System for Exercise Testing) system was used for continuous visual monitoring and recording ECG. A 12-lead ECG was taken every minute during all exercise tests. Blood pressure (BP) was determined by the auscultatory technique, using a sphygmomanometer, a pre-gauged adult cuff, and a stethoscope. The first and last Korotkoff sounds were recorded. BP was taken pre-exercise, every two minutes while the subject was exercising, and every minute post-exercise until the patient's BP approached baseline values.

Nutritional and Body Composition Assessment

Subjects reported a food record at baseline and then were asked to keep 6 non-consecutive days of food records during the first 6 weeks and then every 3 weeks during weeks 7-24. Average daily intake in kilocalories (kcal) was calculated using Food Processor SQL Edition (Version 9.5.0, ESHA Research, Salem, Oregon, Copyright 2004). In addition, the Harris-Benedict equation (HBE) with appropriate adjustment for activity level was used to estimate energy requirements (kcal) for each subject.

Assessment of body fat/composition was measured by air displacement plethysmography (ADP) (BOD POD, Life Measurement, Inc., Concord, CA USA) [18]. After body volume was determined, thoracic gas volume was determined in order to allow determination of percentage lean and fat weight. The BOD POD is analogous to underwater weighing without having to go under water (air displacement is used instead of water displacement) and has been used in subjects up to 500 pounds with high accuracy.

Laboratory values measured included serum urea nitrogen and creatinine, urea and creatinine clearances (to calculate glomerular filtration rate), random urine albumin/creatinine and protein/creatinine ratios, 24-hour urine protein excretion, hemoglobin, glycated hemoglobin, lipid profile, and C-reactive protein (CRP). These tests were done at baseline, at the end of exercise training (6 weeks), and at study completion (24 weeks).

Data Analysis

We performed within-group and between-group comparisons using mixed-effect linear regression models that included indicators for group (control vs. intervention), time (in weeks), and an interaction term (group × time). To address the possible correlation of an individual's measures over time, the models included a random effect. For analytic purposes, urine protein data were log transformed in order to normalize the data. A P-value of < 0.05 was taken to be significant.

Results

Twenty patients were recruited and signed the consent form. One subject did not qualify based on screening laboratory tests. Of the remaining 19 subjects, 6 were dropped from the study due to a positive stress test (2 patients), investigator decision (2 patients), patient wish (1 patient), and commencement of hemodialysis (1 patient). Thirteen subjects were then randomized, 7 to the exercise group and 6 to the control group. Two of the 6 control subjects were dropped subsequent to randomization and prior to any testing (due to investigator decision and patient wish, respectively), leaving 4 subjects in the control group. All subjects were male; mean age was 66 (range 55-81).

Data for the exercise and control group patients are given in Tables 3 and 4. Thrice weekly exercise training for 6 weeks followed by 18 weeks of home exercise resulted in an increase in exercise duration during treadmill testing at 6 weeks, which persisted until 24 weeks. There was a tendency for oxygen consumption at isotime during the treadmill testing to decrease (isotime is defined as a time when workload was the same in all subjects), which was accompanied by a slight decrease in resting systolic blood pressure, again suggesting a training effect. There was also a trend toward a decrease in 24-hour proteinuria (Figure 1). However, there were no significant between-groups effects over time for exercise duration, oxygen consumption at isotime, blood pressure, or 24-hour proteinuria, probably due to the small sample size. Six weeks of exercise training did not affect GFR nor improve hemoglobin or biochemical parameters such as glycated hemoglobin and serum lipids, and did not diminish CRP (as a marker of inflammation). Caloric intake and body weight and composition also did not change with exercise training.
Figure 1

Plot depicting effect of exercise on proteinuria in 7 subjects undergoing exercise training (structured exercise training for 6 weeks followed by home exercise for 18 weeks)

Table 3

Data in Subjects Randomized to Exercise

Exercise Parameters

Baseline

6 weeks

24 weeks

Exercise duration (min)

6.6 ± 2.2

11.3 ± 2.4

10.2 ± 2.8

Maximal oxygen consumption (mL/kg/min)

14.9 ± 1.1

13.8 ± 3.9

15.6 ± 2.4

Oxygen consumption (isotime) (mL/kg/min)

11.9 ± 1.7

10.0 ± 0.7

9.8 ± 1.4

Resting heart rate (bpm)

80 ± 16

82 ± 22

81 ± 21

Maximum heart rate (bpm)

116 ± 16

121 ± 14

118 ± 17

Resting systolic blood pressure (mmHg)

130 ± 28

132 ± 13

113 ± 16

Resting diastolic blood pressure (mmHg)

71 ± 20

71 ± 11

65 ± 10

Maximum systolic blood pressure (mmHg)

182 ± 16

188 ± 24

165 ± 21

Maximum RPP#

21094 ± 3475

22616 ± 1983

19206 ± 1402

Mean ± SD

# rate pressure product = heart rate × systolic blood pressure

Renal Function Parameters

Baseline

6 weeks

24 weeks

Serum creatinine (mg/dL)

2.9 ± 1.5

2.7 ± 1.3

2.8 ± 1.2

Serum urea nitrogen (mg/dL)

64 ± 40

58 ± 48

57 ± 34

Creatinine clearance (mL/min)

64 ± 54

62 ± 40

51 ± 26

Urea clearance (mL/min)

24 ± 20

28 ± 22

26 ± 19

Glomerular filtration rate (mL/min)#

44 ± 36

45 ± 31

39 ± 22

Urine albumin/creatinine (mg/g)

327 ± 385

242 ± 260

305 ± 456

Urine protein/creatinine (mg/g)

565 ± 600

419 ± 417

493 ± 544

Urine protein excretion (mg/24 h)

1020 ± 1081

891 ± 831

821 ± 1010

   # (Creatinine clearance + urea clearance)/2

Biochemical Parameters

Baseline

6 weeks

24 weeks

Hemoglobin (g/dL)

12.7 ± 2.1

12.7 ± 2.2

12.5 ± 1.8

Total cholesterol (mg/dL)

125 ± 25

116 ± 17

128 ± 25

Low density cholesterol (mg/dL)

59 ± 17

51 ± 16

54 ± 11

High density cholesterol (mL/min)

38 ± 6

37 ± 5

39 ± 7

Triglycerides (mg/dL)

137 ± 45

144 ± 60

179 ± 89

Glycated hemoglobin (%)

7.4 ± 1.1

7.5 ± 1.2

8.3 ± 2.4

C-reactive protein (mg/dL)

0.55 ± 0.72

0.72 ± 0.99

0.89 ± 0.92

Nutrition/Body Composition Parameters

Baseline

6 weeks

24 weeks

Calorie intake (kcal/day)

1878 ± 563

2011 ± 396

1939 ± 656

Body weight (kg)

116 ± 27

116 ± 26

115 ± 23

Fat weight (%)

40 ± 3

40 ± 3

40 ± 4

Lean weight (%)

60 ± 3

60 ± 3

60 ± 4

Table 4

Data in Control Subjects

Exercise Parameters

Baseline

6 weeks

24 weeks

Exercise duration (min)

4.3 ± 1.1

5.5 ± 3.2

6.6 ± 2.1

Maximal oxygen consumption (mL/kg/min)

10.9 ± 1.0

11.8 ± 2.0

11.9 ± 1.3

Oxygen consumption (isotime) (mL/kg/min)

9.1 ± 0.3

9.0 ± 0.2

9.8 ± 0.5

Resting heart rate (bpm)

75 ± 16

76 ± 10

70 ± 19

Maximum heart rate (bpm)

112 ± 16

107 ± 16

105 ± 13

Resting systolic blood pressure (mmHg)

157 ± 14

156 ± 23

136 ± 5

Resting diastolic blood pressure (mmHg)

83 ± 20

77 ± 12

77 ± 8

Maximum systolic blood pressure (mmHg)

207 ± 28

188 ± 47

184 ± 22

Maximum RPP#

23219 ± 6046

20939 ± 7809

19373 ± 4215

Mean ± SD

# rate pressure product = heart rate × systolic blood pressure

Renal Function Parameters

Baseline

6 weeks

24 weeks

Serum creatinine (mg/dL)

2.3 ± 0.1

2.1 ± 0.2

2.1 ± 0.4

Serum urea nitrogen (mg/dL)

45 ± 11

48 ± 12

50 ± 18

Creatinine clearance (mL/min)

66 ± 19

54 ± 22

64 ± 10

Urea clearance (mL/min)

28 ± 0.2

18 ± 5.7

19 ± 0.5

Glomerular filtration rate (mL/min)#

47 ± 9.5

36 ± 14

41 ± 5.3

Urine albumin/creatinine (mg/g)

156 ± 148

162 ± 173

221 ± 304

Urine protein/creatinine (mg/g)

347 ± 178

305 ± 186

387 ± 374

Urine protein excretion (mg/24 h)

542 ± 258

383 ± 256

490 ± 237

   # (Creatinine clearance + urea clearance)/2

Biochemical Parameters

Baseline

6 weeks

24 weeks

Hemoglobin (g/dL)

11.8 ± 1.9

12.0 ± 1.8

11.9 ± 1.3

Total cholesterol (mg/dL)

152 ± 38

160 ± 53

146 ± 31

Low density cholesterol (mg/dL)

75 ± 24

80 ± 41

69 ± 22

High density cholesterol (mL/min)

33 ± 6

31 ± 3

31 ± 4

Triglycerides (mg/dL)

223 ± 92

245 ± 44

225 ± 104

Glycated hemoglobin (%)

8.2 ± 1.7

8.7 ± 2.6

8.1 ± 3.7

C-reactive protein (mg/dL)

1.7 ± 2.4

0.73 ± 0.32

1.17 ± 0.71

Body Composition Parameters

Baseline

6 weeks

24 weeks

Calorie intake (kcal/day)

1869 ± 13

2165 ± 658

2192 ± 537

Body weight (kg)

140 ± 15

139 ± 15

136 ± 20

Fat weight (%)

50 ± 5

53 ± 3

50 ± 5

Lean weight (%)

50 ± 5

47 ± 3

50 ± 5

Discussion

To our knowledge, this is the first randomized controlled trial that has examined the effects of exercise training in diabetic patients with CKD. However, there have been a few previous studies that have examined the effects of exercise on renal function in primarily non-diabetic CKD patients. Boyce et al. found, in a crossover-design trial, that four months of exercise training, via stationary cycling, in sixteen non-dialysis CKD subjects (of whom 8 completed the trial) decreased blood pressure (systolic and diastolic), increased peak oxygen consumption, but had no effect on declining GFR [19]. In another non-randomized trial, Clyne et al. found that exercise training for 3 months via bicycle ergometry in 10 predialytic CKD patients increased maximal exercise capacity and decreased heart rate at equal load and increased thigh muscular function assessed by static and dynamic endurance, but these benefits were not associated with improved hemoglobin, GFR, blood pressure, or echocardiographic findings [20]. In a randomized study of 30 patients with moderate CKD, Eidemak et al. found that aerobic exercise increased maximum work capacity but had no effect on declining GFR over a 20-month observation period [21]. The lack of effect of land-based exercise on renal function is consistent with experimental findings in rats with renal mass reduction, in which treadmill exercise for 60 days did not improve GFR [22]. In distinction to these primarily negative studies, Pechter et al. reported that a 12-week low-intensity aquatic exercise program in 26 patients with mild to moderate CKD resulted in decreased blood pressure, decreased proteinuria, and a slight improvement in GFR. This was associated with a decrease in systolic and diastolic blood pressure and oxidative stress indices (lipid peroxidation products and reduced glutathione) [23]. Aquatic exercise may thus decrease proteinuria and improve GFR, as was shown previously in rats with subtotal nephrectomy [24]. However, the results of this study must be interpreted with caution due to its non-randomized design. Moreover, whether or not the putative salutary effects of aquatic exercise can be extended to land-based aerobic exercise is unclear, as water immersion is known to improve renal function, probably due to an improvement in renal hemodyanamics associated with decreases in vasopressor and increases in vasodepressor hormones [25].

Diabetic patients with CKD and overt albuminuria typically develop progressive kidney failure [7]. Therefore, the effects of exercise on albuminuria and progression of kidney disease in this population is of great clinical importance. Albuminuria in type 2 diabetic patients is associated with endothelial dysfunction and low-grade inflammation [26]. Exercise is associated with a decrease in inflammation, and there is a positive association between inflammation and microalbuminuria [27]. Thus an exercise-induced reduction in inflammation and/or oxidative stress might be expected to decrease proteinuria. Cytokines and inflammatory markers may directly mediate glomerular and renal damage leading to albuminuria and renal failure [28]. We did not find significant changes in proteinuria or C-reactive protein in our study, but this can probably be explained by the substantial intra-patient variability and small sample size.

We also did not find any changes in glycated hemoglobin, lipid profile, or body weight or composition. Although all subjects did receive nutritional counseling, they did not specifically undergo caloric restriction or other forms of dietary modification. It is likely that a more prolonged and intensive exercise training program or an exercise program coupled with calorie restriction would have been required to result in weight loss and a decrease in fat mass. In this regard, long-term (1 year) aerobic coupled with resistance training has been reported to improve these parameters in type 2 diabetic patients without kidney disease and only mild obesity (BMI 30) [13]. Renal function and proteinuria were not assessed in that study.

Conclusion

In summary, we have demonstrated in a pilot study that exercise training in obese diabetic patients with CKD is feasible and may have clinical benefits. A larger-scale randomized controlled trial to determine the effects of exercise on renal functions, cardiovascular fitness, inflammation, and oxidative stress in diabetic patients with CKD is planned.

Declarations

Authors’ Affiliations

(1)
Medicine Service, Veterans Affairs Hospital
(2)
Research Service, Veterans Affairs Hospital
(3)
Nutrition and Food Service, Veterans Affairs Hospital
(4)
Spinal Cord Injury (SCI) QUERI and Center for Management of Complex Chronic Care, Veterans Affairs Hospital
(5)
Department of Medicine, Loyola University Medical Center
(6)
Department of Medical-Surgical Nursing, University of Illinois College of Nursing

References

  1. International Diabetes Foundation: Diabetes: A Global Threat. 2006, Brussels, Belgium: International Diabetes Foundation, 1-15.Google Scholar
  2. Alberti G, Zimmet P, Shaw J, Bloomgarden Z, Kaufman F, Silink M: Type 2 diabetes in the young: the evolving epidemic: the international diabetes federation consensus workshop. Diabetes Care. 2004, 27: 1798-1811. 10.2337/diacare.27.7.1798.View ArticlePubMedGoogle Scholar
  3. Booth FW, Chakravarthy MV, Gordon SE, Spangenburg EE: Waging war on physical inactivity: using modern molecular ammunition against an ancient enemy. J Appl Physiol. 2002, 93: 3-30.View ArticlePubMedGoogle Scholar
  4. US Renal Data System: USRDS 2008 Annual Data Report. 2008, Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney DiseasesGoogle Scholar
  5. UK Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998, 352: 837-853. 10.1016/S0140-6736(98)07019-6.View ArticleGoogle Scholar
  6. Stratton IM, Cull CA, Adler AI, Matthews DR, Neil HA, Holman RR: Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). Diabetologia. 2008, 49: 1761-1769. 10.1007/s00125-006-0297-1.View ArticleGoogle Scholar
  7. Rossing K, Christensen PK, Hovind P, Parving HH: Remission of nephrotic-range albuminuria reduces risk of end-stage renal disease and improves survival in type 2 diabetic patients. Diabetologia. 2005, 48: 2241-2247. 10.1007/s00125-005-1937-6.View ArticlePubMedGoogle Scholar
  8. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O: Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003, 348: 383-393. 10.1056/NEJMoa021778.View ArticlePubMedGoogle Scholar
  9. Dunstan DW, Mori TA, Puddey IB, Beilin LJ, Burke V, Morton AR, Stanton KG: The independent and combined effects of aerobic exercise and dietary fish intake on serum lipids and glycemic control in NIDDM. A randomized controlled study. Diabetes Care. 1997, 20: 913-921. 10.2337/diacare.20.6.913.View ArticlePubMedGoogle Scholar
  10. Lindstrom J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemio K, Hamalainen H, Harkonen P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Paturi M, Sundvall J, Valle TT, Uusitupa M, Tuomilehto J: Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006, 368: 1673-1679. 10.1016/S0140-6736(06)69701-8.View ArticlePubMedGoogle Scholar
  11. Torjesen PA, Birkeland KI, Anderssen SA, Hjermann I, Holme I, Urdal P: Lifestyle changes may reverse development of the insulin resistance syndrome. The Oslo Diet and Exercise Study: a randomized trial. Diabetes Care. 1997, 20: 26-31. 10.2337/diacare.20.1.26.View ArticlePubMedGoogle Scholar
  12. Vanninen E, Uusitupa M, Siitonen O, Laitinen J, Lansimies E: Habitual physical activity, aerobic capacity and metabolic control in patients with newly-diagnosed type 2 (non-insulin-dependent) diabetes mellitus: effect of 1-year diet and exercise intervention. Diabetologia. 1992, 35: 340-346. 10.1007/BF00401201.View ArticlePubMedGoogle Scholar
  13. Balducci S, Leonetti F, Di Mario U, Fallucca F: Is a long-term aerobic plus resistance training program feasible for and effective on metabolic profiles in type 2 diabetic patients?. Diabetes Care. 2004, 27: 841-842. 10.2337/diacare.27.3.841.View ArticlePubMedGoogle Scholar
  14. Kishimoto H, Taniguchi A, Fukushima M, Sakai M, Tokuyama K, Oguma T, Nin K, Nagata I, Hayashi R, Kawano M, Hayashi K, Tsukamoto Y, Okumura T, Nagasaka S, Mizutani H, Nakai Y: Effect of short-term low-intensity exercise on insulin sensitivity, insulin secretion, and glucose and lipid metabolism in non-obese Japanese type 2 diabetic patients. Horm Metab Res. 2002, 34: 27-31. 10.1055/s-2002-19963.View ArticlePubMedGoogle Scholar
  15. American Diabetes Association: Standards of medical care in diabetes-2007. Diabetes Care. 2007, 30 (Suppl 1): S4-S41.View ArticleGoogle Scholar
  16. Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B: Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2006, 49: 1711-1721. 10.1007/s00125-006-0316-2.View ArticlePubMedGoogle Scholar
  17. Sigal RJ, Kenny GP, Wasserman DH, Castaneda-Sceppa C, White RD: Physical activity/exercise and type 2 diabetes: a consensus statement from the American Diabetes Association. Diabetes Care. 2006, 29: 1433-1438. 10.2337/dc06-9910.View ArticlePubMedGoogle Scholar
  18. McCrory MA, Gomex TD, Bernauer EM, Mole PA: Evaluation of a new air displacement plethysmograph for measuring human body composition. Med Sci Sport Exerc. 1995, 27: 1686-1691.View ArticleGoogle Scholar
  19. Boyce ML, Robergs RA, Avasthi PS, Roldan C, Foster A, Montner P, Stark D, Nelson C: Exercise training by individuals with predialysis renal failure: cardiorespiratory endurance, hypertension, and renal function. Am J Kidney Dis. 1997, 30: 180-192. 10.1016/S0272-6386(97)90051-2.View ArticlePubMedGoogle Scholar
  20. Clyne N, Ekholm J, Jogestrand T, Lins LE, Pehrsson SK: Effects of exercise training in predialytic uremic patients. Nephron. 1991, 59: 84-89. 10.1159/000186524.View ArticlePubMedGoogle Scholar
  21. Eidemak I, Haaber AB, Feldt-Rasmussen B, Kanstrup IL, Strandgaard S: Exercise training and the progression of chronic renal failure. Nephron. 1997, 75: 36-40. 10.1159/000189497.View ArticlePubMedGoogle Scholar
  22. Bergamaschi CT, Boim MA, Moura LA, Piçarro IC, Schor N: Effects of long-term training on the progression of chronic renal failure in rats. Med Sci Sports Exerc. 1997, 29: 169-174.View ArticlePubMedGoogle Scholar
  23. Pechter U, Ots M, Mesikepp S, Zilmer K, Kullissaar T, Vihalemm T, Zilmer M, Maaroos J: Beneficial effects of water-based exercise in patients with chronic kidney disease. Int J Rehabil Res. 2003, 26: 153-156. 10.1097/00004356-200306000-00013.View ArticlePubMedGoogle Scholar
  24. Heifets M, Davis TA, Tegtmeyer E, Klahr S: Exercise training ameliorates progressive renal disease in rats with subtotal nephrectomy. Kidney Int. 1987, 32: 815-819. 10.1038/ki.1987.281.View ArticlePubMedGoogle Scholar
  25. Epstein M: Renal effects of head-out water immersion in humans: a 15-year update. Physiol Rev. 1992, 72: 563-621.PubMedGoogle Scholar
  26. Stehouwer CD, Gall MA, Twisk JW, Knudsen E, Emeis JJ, Parving HH: Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes. 2002, 51: 1157-1165. 10.2337/diabetes.51.4.1157.View ArticlePubMedGoogle Scholar
  27. Barzilay JI, Peterson D, Cushman M, Heckbert SR, Cao JJ, Blaum C, Tracy RP, Klein R, Herrington DM: The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension: the cardiovascular health study. Am J Kidney Dis. 2004, 44: 25-34. 10.1053/j.ajkd.2004.03.022.View ArticlePubMedGoogle Scholar
  28. Klahr S: Mechanisms of progression of chronic renal damage. J Nephrol. 1999, 12 (suppl 2): S53-S62.PubMedGoogle Scholar

Copyright

© Leehey et al; licensee BioMed Central Ltd. 2009

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement